These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18814339)

  • 1. In-vitro activities of current antimicrobial agents against isolates of pyoderma.
    Ramana KV; Mohanty SK; Kumar A
    Indian J Dermatol Venereol Leprol; 2008; 74(4):430. PubMed ID: 18814339
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of neomycin and other antibiotics on pyogenic bacteria: in vitro effect on bacteria isolated from cutaneous pyogenic infections.
    LIVINGOOD CS; HEAD CE; SUTTER RM; ENGLEY FB
    AMA Arch Derm Syphilol; 1954 Jan; 69(1):43-57. PubMed ID: 13113722
    [No Abstract]   [Full Text] [Related]  

  • 3. [The etiological spectrum and immunosuppressive properties of the causative agents of pyoderma].
    Gaĭdash IS; Flegontova VV; Kazimirko NK; Kazimirko VK; Pil'kevich NB; Volobueva LN; Gavrik SIu
    Mikrobiol Z; 1999; 61(3):23-9. PubMed ID: 10483229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections.
    Ganière JP; Médaille C; Etoré F
    Res Vet Sci; 2004 Aug; 77(1):67-71. PubMed ID: 15120955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
    Azadian BS; Talboys CA; Roberts AP
    J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimicrobial activities of microbial strains isolated from soil of stressed ecological niches of Eastern Uttar Pradesh, India.
    Singh V; Praveen V; Banga J; Tripathi CK
    Indian J Exp Biol; 2009 Apr; 47(4):298-303. PubMed ID: 19382727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of lomefloxacin (SC 47111 or NY-198), a new quinolone antimicrobial, against clinical isolates of common pathogens.
    Sonstein SA; Dahlgren J
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):21S-28S. PubMed ID: 2791494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Rapid System for Antimicrobial Identification and Antimicrobial Susceptibility Testing in Pediatric Bloodstream Infections.
    Ward E; Weller K; Gomez J; Roman K; Cárdenas AM
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29925640
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro comparison of ciprofloxacin, ofloxacin, and povidone-iodine for surgical prophylaxis.
    Keverline MR; Kowalski RP; Dhaliwal DK
    J Cataract Refract Surg; 2002 Jun; 28(6):915-6. PubMed ID: 12036617
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones.
    Graves A; Henry M; O'Brien TP; Hwang DG; Van Buskirk A; Trousdale MD
    Cornea; 2001 Apr; 20(3):301-5. PubMed ID: 11322420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antibacterial activities of broad spectrum quinolones against clinical bacterial isolates.
    Matsumoto T; Tateda K; Ishii Y; Ohno A; Miyazaki S; Yamaguchi K
    Drugs; 1995; 49 Suppl 2():219-21. PubMed ID: 8549309
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative in vitro activity of lomefloxacin (SC 47111 or NY-198) against fresh clinical bacterial isolates.
    Wright DN; Saxon B; Matsen JM
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):7S-11S. PubMed ID: 2791501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antimicrobial activity of gatifloxacin against 873 clinical isolates from respiratory tract, urinary tract and surgical infections during 1997-1998 in Japan.
    Tsurumaki Y; Manda H; Takei M; Hosaka M
    J Antimicrob Chemother; 2000 May; 45(5):685-9. PubMed ID: 10797094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro antibacterial activities of broad spectrum quinolones against clinical bacterial isolates].
    Ishii Y; Ohno A; Yamaguchi K
    Jpn J Antibiot; 1994 Jan; 47(1):22-8. PubMed ID: 8114270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro pharmacodynamics of ofloxacin and ciprofloxacin against common ocular pathogens.
    Eiferman RA
    Cornea; 2001 May; 20(4):438-9. PubMed ID: 11333340
    [No Abstract]   [Full Text] [Related]  

  • 16. Multicenter drug study assessing in vitro antibiotic susceptibilities of ocular isolates.
    Baum J
    Cornea; 1998 Sep; 17(5):571-2. PubMed ID: 9756455
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative activities of six different fluoroquinolones against 9,682 clinical bacterial isolates from 20 European university hospitals participating in the European SENTRY surveillance programme. The SENTRY participants group.
    Schmitz FJ; Verhoef J; Fluit AC
    Int J Antimicrob Agents; 1999 Aug; 12(4):311-7. PubMed ID: 10493607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility testing of BMS-284756 by the BSAC standardized disc testing method.
    Andrews JM; Wise R
    J Antimicrob Chemother; 2001 Aug; 48(2):322-4. PubMed ID: 11481314
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro antimicrobial activity and postantibiotic effect of lomefloxacin, a new difluoroquinolone.
    Molinari G; Bandelloni R; Paglia P; Debbia E; Schito GC
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):53S-56S. PubMed ID: 2791499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of Plicosepalus acaciae.
    Elegami AA; Elnima EI; Muddathir AK; Omer ME
    Fitoterapia; 2001 May; 72(4):431-4. PubMed ID: 11395272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.